Common cosmetic labeling mistakes to catch before printing

Eight recurring problems

1. Classification is assumed: a cream, serum, or shampoo is called a cosmetic without reviewing therapeutic, structure/function, or disease claims that may signal drug intended use.
2. The identity statement is vague: branding and benefit language displace the common or usual description of what the product is.
3. Quantity is copied from another market: units, location, package display area, and prominence are not checked on the final U.S. artwork.
4. The ingredient list is built from a supplier sheet: the team does not reconcile the finished formula, sub-ingredients, colors, fragrance components, or declaration order.
5. Company information lacks an evidence trail: a business name appears, but its label role, place of business, and responsible-person records are unclear.
6. Warnings are treated as boilerplate: restricted ingredients, professional use, aerosols, eye-area products, user groups, and foreseeable misuse are not considered.
7. Claims are reviewed one line at a time: product names, images, before-and-after material, testimonials, directions, websites, and marketplace copy are omitted.
8. Old artwork survives a formula change: the approved proof is not tied to the formula, package, review date, source version, and open issues.

A stronger release sequence

Freeze the formula, intended use, package configuration, and all claim-bearing material. Compare the final-size proof with every panel and the actual container. Resolve classification first, then identity and quantity, ingredient declaration, business details, warnings, directions, and claims. Keep a visible review queue for unreadable or contradictory evidence and rerun the check after any material change.

Official starting points

• FDA Cosmetics Labeling Guide
• 21 CFR Part 701

Fix the underlying issue